
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
FDG-PET/CT in Lymphoma: Where Do We Go Now?
Yassine Al Tabaa, Clément Bailly, Salim Kanoun
Cancers (2021) Vol. 13, Iss. 20, pp. 5222-5222
Open Access | Times Cited: 29
Yassine Al Tabaa, Clément Bailly, Salim Kanoun
Cancers (2021) Vol. 13, Iss. 20, pp. 5222-5222
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
PET/CT in Non-Hodgkin Lymphoma: An Update
Lucia Zanoni, Davide Bezzi, Cristina Nanni, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 320-351
Closed Access | Times Cited: 42
Lucia Zanoni, Davide Bezzi, Cristina Nanni, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 320-351
Closed Access | Times Cited: 42
FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects
Akram Al‐Ibraheem, Ahmed Saad Abdlkadir, Malik E. Juweid, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1063-1063
Open Access | Times Cited: 19
Akram Al‐Ibraheem, Ahmed Saad Abdlkadir, Malik E. Juweid, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1063-1063
Open Access | Times Cited: 19
Automated Lugano Metabolic Response Assessment in 18 F-Fluorodeoxyglucose–Avid Non-Hodgkin Lymphoma With Deep Learning on 18 F-Fluorodeoxyglucose–Positron Emission Tomography
Skander Jemaa, Souhila Ounadjela, Xiaoyong Wang, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 25, pp. 2966-2977
Open Access | Times Cited: 8
Skander Jemaa, Souhila Ounadjela, Xiaoyong Wang, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 25, pp. 2966-2977
Open Access | Times Cited: 8
Emerging Role of [18F]FLT PET/CT in Lymphoid Malignancies: A Review of Clinical Results
Anna Nappi, Giulia Santo, Lorenzo Jonghi-Lavarini, et al.
Hematology Reports (2024) Vol. 16, Iss. 1, pp. 32-41
Open Access | Times Cited: 7
Anna Nappi, Giulia Santo, Lorenzo Jonghi-Lavarini, et al.
Hematology Reports (2024) Vol. 16, Iss. 1, pp. 32-41
Open Access | Times Cited: 7
PET/CT in Hodgkin Lymphoma: An Update
Akram Al‐Ibraheem, Felix M. Mottaghy, Malik E. Juweid
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 303-319
Closed Access | Times Cited: 22
Akram Al‐Ibraheem, Felix M. Mottaghy, Malik E. Juweid
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 303-319
Closed Access | Times Cited: 22
Prognostic Value of18F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study
Thomas Carlier, Gauthier Frécon, Diana Mateus, et al.
Journal of Nuclear Medicine (2023) Vol. 65, Iss. 1, pp. 156-162
Open Access | Times Cited: 11
Thomas Carlier, Gauthier Frécon, Diana Mateus, et al.
Journal of Nuclear Medicine (2023) Vol. 65, Iss. 1, pp. 156-162
Open Access | Times Cited: 11
A multi-instance tumor subtype classification method for small PET datasets using RA-DL attention module guided deep feature extraction with radiomics features
Zhaoshuo Diao, Huiyan Jiang
Computers in Biology and Medicine (2024) Vol. 174, pp. 108461-108461
Closed Access | Times Cited: 4
Zhaoshuo Diao, Huiyan Jiang
Computers in Biology and Medicine (2024) Vol. 174, pp. 108461-108461
Closed Access | Times Cited: 4
Automated Evaluation of Lymphoma Treatment Response: Integrating Delta Radiomics and Deep Learning from 2-[18F]FDG PET/CT
Jakub Mitura, Rafał Jóźwiak, Beata Chrapko, et al.
(2025)
Closed Access
Jakub Mitura, Rafał Jóźwiak, Beata Chrapko, et al.
(2025)
Closed Access
PET scan for the detection of histological transformation of follicular lymphoma: A systematic review of diagnostic performance
Marc Sorigué, Miloš D. Miljković, Pablo Mozas
Blood Reviews (2025), pp. 101270-101270
Closed Access
Marc Sorigué, Miloš D. Miljković, Pablo Mozas
Blood Reviews (2025), pp. 101270-101270
Closed Access
Personalized baseline and residual TMTV influence treatment response and outcomes in relapsed/refractory lymphomas: results from the GATA study
Solène Malmon, Olivier Casasnovas, Marguerite Fournier, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Solène Malmon, Olivier Casasnovas, Marguerite Fournier, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Prognostic Value of Very Early Interim FDG PET/CT After Single Cycle of Chemotherapy for 10-Year Survival in Diffuse Large B-Cell Lymphoma
Eun Ji Han, Hye Lim Park, Seung‐Ah Yahng, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 926-926
Open Access
Eun Ji Han, Hye Lim Park, Seung‐Ah Yahng, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 926-926
Open Access
[18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription
Johannes H.A.M. Kaanders, Johan Bussink, Erik H.J.G. Aarntzen, et al.
Seminars in Radiation Oncology (2023) Vol. 33, Iss. 3, pp. 287-297
Open Access | Times Cited: 4
Johannes H.A.M. Kaanders, Johan Bussink, Erik H.J.G. Aarntzen, et al.
Seminars in Radiation Oncology (2023) Vol. 33, Iss. 3, pp. 287-297
Open Access | Times Cited: 4
Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial
Caroline Bodet‐Milin, Cyrille Morvant, Thomas Carlier, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Caroline Bodet‐Milin, Cyrille Morvant, Thomas Carlier, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Long-Axial Field-of-View PET Imaging in Patients with Lymphoma
Clemens Mingels, Hande Nalbant, Hasan Sari, et al.
PET Clinics (2024) Vol. 19, Iss. 4, pp. 495-504
Closed Access | Times Cited: 1
Clemens Mingels, Hande Nalbant, Hasan Sari, et al.
PET Clinics (2024) Vol. 19, Iss. 4, pp. 495-504
Closed Access | Times Cited: 1
Metabolic Biomarkers in B-Cell Lymphomas for Early Diagnosis and Prediction, as Well as Their Influence on Prognosis and Treatment
Abdullah Alfaifi, Salem Bahashwan, Mohammed Alsaadi, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 394-394
Open Access | Times Cited: 7
Abdullah Alfaifi, Salem Bahashwan, Mohammed Alsaadi, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 394-394
Open Access | Times Cited: 7
Balancing the Therapeutic Ratio in DLBCL Requires Appropriate, Individualized Patient Selection Rather Than Broad Elimination of Radiation Therapy
Belinda A. Campbell, Richard L. Bakst, Sarah A. Milgrom, et al.
International Journal of Radiation Oncology*Biology*Physics (2022) Vol. 113, Iss. 3, pp. 479-488
Closed Access | Times Cited: 7
Belinda A. Campbell, Richard L. Bakst, Sarah A. Milgrom, et al.
International Journal of Radiation Oncology*Biology*Physics (2022) Vol. 113, Iss. 3, pp. 479-488
Closed Access | Times Cited: 7
Prognostic value of whole-body dynamic 18F-FDG PET/CT Patlak in diffuse large B-cell lymphoma
Jiankang Yin, Hui Wang, Gan Zhu, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19749-e19749
Open Access | Times Cited: 3
Jiankang Yin, Hui Wang, Gan Zhu, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19749-e19749
Open Access | Times Cited: 3
Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group
Yassine Al Tabaa, Rene Oliver Casasnovas, C. Baillet, et al.
Blood Advances (2023) Vol. 7, Iss. 14, pp. 3735-3738
Open Access | Times Cited: 2
Yassine Al Tabaa, Rene Oliver Casasnovas, C. Baillet, et al.
Blood Advances (2023) Vol. 7, Iss. 14, pp. 3735-3738
Open Access | Times Cited: 2
Tumor Size Measurements for Predicting Hodgkin’s and Non-Hodgkin’s Lymphoma Response to Treatment
Maria Kallergi, Αλέξανδρος Γεωργακόπουλος, Vassiliki Lyra, et al.
Metabolites (2022) Vol. 12, Iss. 4, pp. 285-285
Open Access | Times Cited: 3
Maria Kallergi, Αλέξανδρος Γεωργακόπουλος, Vassiliki Lyra, et al.
Metabolites (2022) Vol. 12, Iss. 4, pp. 285-285
Open Access | Times Cited: 3
Role of interim positron emission tomography/computed tomography in assessment of lymphoma treatment response
Salma M. Borg, Gehad A. Saleh, Nihal M. Batouty, et al.
The Egyptian Journal of Radiology and Nuclear Medicine (2024) Vol. 55, Iss. 1
Open Access
Salma M. Borg, Gehad A. Saleh, Nihal M. Batouty, et al.
The Egyptian Journal of Radiology and Nuclear Medicine (2024) Vol. 55, Iss. 1
Open Access
Haemato-radiology: the role of the radiologist at MDT
Omnya Ahmed, Katherine Ordidge, Tahir Hussain, et al.
British Journal of Radiology (2024) Vol. 97, Iss. 1163, pp. 1725-1739
Closed Access
Omnya Ahmed, Katherine Ordidge, Tahir Hussain, et al.
British Journal of Radiology (2024) Vol. 97, Iss. 1163, pp. 1725-1739
Closed Access
PET-based lesion graphs meet clinical data: An interpretable cross-attention framework for DLBCL treatment response prediction
Oriane Thiery, Mira Rizkallah, Clément Bailly, et al.
Computerized Medical Imaging and Graphics (2024) Vol. 120, pp. 102481-102481
Open Access
Oriane Thiery, Mira Rizkallah, Clément Bailly, et al.
Computerized Medical Imaging and Graphics (2024) Vol. 120, pp. 102481-102481
Open Access
Effect of some physiological and technical factors on Effective Dose Estimation of Patients Administered with 18F-FDG in PET/CT
Nourhan M. Elsoudy, Mekhail Anwar, Hanan Hussien, et al.
Radiation Physics and Chemistry (2024), pp. 112438-112438
Closed Access
Nourhan M. Elsoudy, Mekhail Anwar, Hanan Hussien, et al.
Radiation Physics and Chemistry (2024), pp. 112438-112438
Closed Access
Foreign body-type giant cell reaction with extensive granulation tissue and intense inflammation after chemotherapy mimicking residual lymphoma on FDG PET
Sakib Kazi, Stavros Raptis, Farzad Abbaspour, et al.
European Journal of Hybrid Imaging (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Sakib Kazi, Stavros Raptis, Farzad Abbaspour, et al.
European Journal of Hybrid Imaging (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 1